ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
New York Times article on drug approved for Fibromyalgia
Tuesday 15 January 2008
The article, written by Alex Berenson, begins:
“Fibromyalgia is a real disease. Or so says Pfizer in a new television advertising campaign for Lyrica, the first medicine approved to treat the pain condition, whose very existence is questioned by some doctors.”
Berenson goes on to state:
“For patient advocacy groups and doctors who specialize in fibromyalgia, the Lyrica approval is a milestone. They say they hope Lyrica and two other drugs that may be approved this year will legitimize fibromyalgia, just as Prozac brought depression into the mainstream.
But other doctors – including the one who wrote the 1990 paper that defined fibromyalgia but who has since changed his mind – say that the disease does not exist and that Lyrica and the other drugs will be taken by millions of people who do not need them.”
However, later in the article Berenson explains the use ofLyricafor Fibromyalgia:
“Because fibromyalgia patients typically do not respond to conventional painkillers like aspirin, drug makers are focusing on medicines like Lyrica that affect the brain and the perception of pain.”
You can read the full article here:
The New York Times runs a subscription service with its articles. If the above link no longer works, you can download the article here:
The Lyrica television commercial